Are your investments going to fail you this year?
-
Top Small Cap Stock # 5 – Hi-Tech Pharmacal (HITK)
Hi-Tech Pharmacal (HITK) is scheduled as one of the last companies
to post a quarterly report this earnings season. However, if its last quarterly report in December is any indication, this pick’s earnings are well
worth waiting for. In its last report, Hi-Tech’s earnings rose 566.7% to $7.4 million or 60 cents per share compared with $1.1 million or 9 cents
per share in the same quarter a year ago, while sales rose 62.9% in the same period.This generic pharmaceutical company offers a wide range of innovative medications, treating everything from allergies to arthritis and should see
continued growth in the months ahead.How Do the Stocks in Your Portfolio Measure Up?
Designed to give stock analysis on nearly 5,000 stocks in easy-to-interpret A to F letter grades, Portfolio Grader is a great way to rank your
current or future investments, and it’s completely FREE! Put the power of
Portfolio Grader to work for you!







Comments are currently unavailable. Please check back soon.